Guest guest Posted May 15, 2010 Report Share Posted May 15, 2010 Novel Ad-ISF35 immune therapy for CLL explained http://bcrfund.net/news/story_cllvaccine.html Infection by a modified cold virus Ad-ISF35 is thought to induce innate immunity against the infected abnormal lymphocytes. Ad-ISF35 is also thought to reactivate genes that restore sensitivity to chemotherapy. Clinical trial http://clinicaltrials.gov/ct2/show/NCT00942409 for CLL and NHL Karl Schwartz www.Lymphomation.org Evidence-based information on lymphoma, independent of health industry funding Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.